Scientific deep-dive

Is Celsius Good for Weight Loss? Honest Evidence Review

Celsius is an energy drink, not a weight-loss drug. The thermogenic claim rests on one small acute study (Dalbo 2008, n=19) showing a ~30-50 kcal bump for 3 hours. The 28-day follow-up (Roberts 2008) found no body-composition change. 200 mg caffeine per can has real cardiac…

By Eli Marsden · Founding Editor
Editorially reviewed (not clinically reviewed) · How we verify contentLast reviewed
11 min read·8 citations

Celsius is a sugar-free energy drink, not a weight-loss drug. The “burns calories” marketing rests on one small acute study in 19 young adults (Dalbo 2008[1]) showing a roughly 12 kcal-per-hour bump in resting energy expenditure for about 3 hours after drinking the product, plus the well-documented general caffeine-thermogenesis effect of about 50 to 100 kcal per day at 200 to 300 mg caffeine (Astrup 1990[3]). The same Auburn group's 28-day follow-up (Roberts 2008[2]) found no significant change in body composition. There is no published RCT showing Celsius produces weight loss when calories are not already restricted. For magnitude context, the largest GLP-1 trials produced 14.9% to 20.9% body weight reduction over a year (Wilding 2021 STEP-1[6]; Jastreboff 2022 SURMOUNT-1[7]). Celsius is not in the same intervention category. Here is what the evidence does and does not say, plus the cardiac, sweetener, and GLP-1 interaction issues worth knowing.

The honest summary

  • Celsius is an energy drink, not a weight-loss drug. A 12 oz can delivers 200 mg caffeine plus a proprietary “MetaPlus” blend (green tea extract, guarana, ginger, chromium picolinate, B vitamins), zero sugar, and sucralose plus erythritol as sweeteners.
  • The “burns calories” claim rests on one small acute study. Dalbo 2008[1] tested 19 young men and women and found a ~12 kcal-per-hour bump in resting energy expenditure for roughly 3 hours after a single serving. Total extra burn: on the order of 30 to 50 kcal — less than a single saltine cracker.
  • The 28-day follow-up showed no body-composition benefit. Roberts 2008[2] took the same product out to 4 weeks in 60 healthy adults and found no significant difference in fat mass, lean mass, or body weight versus placebo.
  • Caffeine alone explains most of the effect. Astrup 1990[3] — the canonical caffeine thermogenesis paper — documented a roughly 50 to 100 kcal-per-day net increase in energy expenditure at 200 to 300 mg caffeine, with measurable heart-rate and blood-pressure increases.
  • There is no published RCT showing Celsius produces weight loss in a free-living population at matched calories, over 12 weeks or more, with body weight as the primary outcome.
  • Two cans plus typical coffee can push daily caffeine over 600 mg, which the FDA general guidance of 400 mg/day for healthy adults clearly exceeds. Cardiac arrhythmia in susceptible patients is a real concern.
  • The erythritol question is unsettled. Witkowski 2023 Nat Med[4] linked higher plasma erythritol to cardiovascular events. The dose, causality, and Celsius-specific implications are still being debated.

What is actually in a can of Celsius

Per the manufacturer label[8], a standard 12 oz Celsius Original contains:

  • 200 mg caffeine — about the equivalent of two strong cups of brewed coffee.
  • 10 calories — zero sugar.
  • Sweeteners: sucralose plus erythritol.
  • “MetaPlus” proprietary blend (1,810 mg total) — green tea extract (with EGCG), guarana seed extract (which itself contains caffeine, baked into the 200 mg total), ginger root, glucuronolactone, and others.
  • 200 mcg chromium picolinate.
  • B vitamins — B2, B5, B6, B12 at roughly 100% Daily Value or more.
  • Electrolytes: small amounts of sodium and calcium.

The marketing positions Celsius as “the official energy drink of the gym” and emphasizes “thermogenic” plus “burns body fat” language. The thermogenic claim is anchored to the Auburn University studies funded by the manufacturer, which we will walk through below. The “burns body fat” claim is what the FDA and FTC generally treat as an implied weight-loss claim, and the evidence for it is weak.

The Dalbo 2008 acute thermogenesis study

Dalbo, Roberts, Stout, Kerksick 2008[1] — published in the Journal of the International Society of Sports Nutrition — tested the acute effect of a single serving of the commercial thermogenic drink (the formula corresponds to Celsius) versus a placebo in 19 healthy young men and women using a randomized double-blind crossover design. Energy expenditure was measured by indirect calorimetry for 3 hours after ingestion.

Findings: resting energy expenditure was roughly 5 to 10% higher on the active drink than on the placebo at the 1, 2, and 3-hour timepoints, plus modest increases in markers of lipolysis (free fatty acids, glycerol). Translated to absolute numbers, that is roughly 10 to 15 kcal-per-hour over baseline, for about 3 hours — on the order of 30 to 50 extra kcal burned across the post-ingestion window. The trial was small (n=19), acute (single serving), and conducted in healthy young adults, not a population with obesity.

Three honest caveats:

  1. The effect is almost entirely caffeine. The Astrup 1990 caffeine-only data[3] already predicts a thermogenic response of this magnitude from 200 mg caffeine in healthy adults. The proprietary blend adds little measurable EE on top.
  2. The kcal numbers are small versus the calorie deficit math. A typical 1-pound-per-week weight loss target is a 500 kcal-per-day deficit. Celsius contributes a one-time 30 to 50 kcal post-drink bump, essentially erased by the 10 kcal in the can itself if you drink it instead of water.
  3. The study was funded by the manufacturer. Industry sponsorship does not invalidate the data, but it is worth knowing that the strongest acute-thermogenesis paper for Celsius came from a research relationship with the company.

The Roberts 2008 28-day follow-up

Roberts, Dalbo, Hassell, Stout, Kerksick 2008[2] — published in the same journal later that year — took the next step: a 28-day intervention with the same product in 60 healthy adults, randomized to active drink, placebo, or non-treatment control. Body composition was measured by DEXA. Resting energy expenditure was measured by indirect calorimetry.

Findings: at 28 days, the active drink group showed no statistically significant change in body weight, fat mass, or lean mass versus placebo. Resting energy expenditure also showed no significant chronic adaptation. The acute post-drink EE bump documented in Dalbo 2008[1] did not translate to a body-composition change at 28 days.

This is the more important paper for the “does it help with weight loss” question, and it is rarely cited in the marketing. The acute-EE finding is the headline. The chronic body-composition non-finding is the buried footnote. Both came from the same research group at the same time.

Caffeine thermogenesis: what the rest of the literature says

Astrup 1990[3] remains the canonical reference for caffeine and energy expenditure in healthy adults. The double-blind placebo-controlled study at 100, 200, and 400 mg caffeine doses found a dose-response thermogenic effect: roughly 50 kcal extra burn over 4 hours at 100 mg, roughly 80 kcal at 200 mg, and roughly 150 kcal at 400 mg. Heart rate and blood pressure also increased dose-dependently.

Extrapolated to a daily basis at habitual caffeine intake of 200 to 300 mg per day, the net thermogenic effect is on the order of 50 to 100 kcal/day. That is real, but small. To translate: at the high end, 100 kcal/day sustained over a year would predict roughly 10 lb of fat loss if every other variable held constant — which they never do, because the body adapts metabolic rate downward in response to a deficit. In free-living populations, sustained caffeine intake does not produce sustained weight loss above and beyond what the diet and exercise pattern would produce without caffeine.

Habitual caffeine drinkers also develop partial tolerance to the thermogenic effect within 1 to 4 weeks. The first can of Celsius for a caffeine-naive adult will produce the largest EE bump. The hundredth can will produce a smaller one.

Why the kcal math does not move the needle

Put the numbers next to a typical weight-loss target:

  • One Celsius: 30 to 50 kcal acute thermogenic bump, minus 10 kcal in the can = roughly 20 to 40 net kcal per serving.
  • One pound per week weight loss target: 500 kcal/day deficit, sustained — that is 3,500 kcal/week.
  • Ratio: a daily Celsius contributes roughly 4 to 8% of the deficit needed. If you skip the planned afternoon walk because the can “gave you energy,” the math goes negative immediately.

Where caffeine drinks can plausibly help a weight-loss plan is indirect: they can support a real workout (where energy expenditure is hundreds of kcal, not tens) and can blunt appetite for some adults, helping with adherence to a deficit. The drink itself is not the intervention. The sustained deficit is.

Sugar-free formulation: sucralose and erythritol

Celsius is sweetened with a combination of sucralose (a non-nutritive sweetener, 0 kcal) and erythritol (a sugar alcohol with a sweetness about 70% of sucrose, roughly 0.24 kcal/g). The total caloric load is 10 kcal per can.

Two recent controversies are worth flagging:

(1) Erythritol and cardiovascular events. Witkowski 2023 Nat Med[4] reported that higher circulating erythritol concentrations were associated with major adverse cardiovascular events in three independent cohorts, and that exogenous erythritol ingestion in healthy volunteers produced platelet activation in vitro. The paper triggered a large debate. Critics noted that erythritol is also produced endogenously, that the observational associations could reflect underlying metabolic disease, and that no causal RCT has demonstrated harm. The Calorie Control Council and several regulatory agencies have maintained that approved erythritol intake remains safe. The question is unsettled. Patients with established cardiovascular disease or strong family history may reasonably choose to limit erythritol pending more data.

(2) Aspartame and IARC. Celsius is not sweetened with aspartame, so the 2023 IARC classification of aspartame as “possibly carcinogenic to humans” (Group 2B) is not directly relevant to Celsius Original. Some Celsius product lines have used other sweetener systems over time. Check the can label for the specific product you are drinking.

Cardiac and blood-pressure considerations

Two hundred milligrams of caffeine per can is a meaningful dose. The FDA general guidance for healthy adults is that up to 400 mg of caffeine per day — about two cans of Celsius, or one Celsius plus two cups of coffee — is not generally associated with negative effects. Above that level, the risk of caffeine-related side effects (tachycardia, palpitations, anxiety, insomnia, gastrointestinal upset, blood pressure increases) rises.

Populations that warrant extra caution:

  • Known cardiac arrhythmia (atrial fibrillation, supraventricular tachycardia, long QT syndrome) — caffeine can trigger or worsen arrhythmia in susceptible patients.
  • Uncontrolled hypertension — the Astrup 1990 caffeine paper[3] documented measurable blood-pressure increases at 200 mg caffeine in healthy adults. Patients on antihypertensive therapy should account for this.
  • Pregnancy — the American College of Obstetricians and Gynecologists guidance limits caffeine to 200 mg/day in pregnancy. One Celsius hits that ceiling.
  • Adolescents — the American Academy of Pediatrics recommends against energy drinks in children and adolescents. Celsius marketing has come under scrutiny for reach into the under-18 demographic.
  • Anxiety disorders and insomnia — the dose and the rapid absorption profile of an iced energy drink consistently amplify both.
  • Patients on stimulants (ADHD medications, decongestants) — the additive sympathomimetic load can produce cardiovascular symptoms.

If you are stacking a Celsius with morning coffee plus a pre-workout supplement, you can easily reach 600 to 800 mg of caffeine per day. That is well above the FDA guidance and materially raises the cardiovascular and anxiety side-effect risk for the average adult.

Celsius and GLP-1 medications (Wegovy, Zepbound, Ozempic, Mounjaro)

GLP-1 receptor agonists slow gastric emptying and produce early satiety. Common side effects include nausea, reflux, constipation, and occasional vomiting (Wharton 2022 clinical practice guidance[5]). Caffeine at the Celsius dose interacts with this physiology in three ways:

  1. Caffeine can amplify nausea. The sympathomimetic load on top of GLP-1-induced delayed gastric emptying is a known nausea trigger. Patients in the first 4 to 8 weeks of GLP-1 dose titration consistently report worse nausea with high-caffeine intake.
  2. Caffeine can worsen reflux. Caffeine relaxes the lower esophageal sphincter, and GLP-1 medications already slow gastric emptying. The combination increases reflux and heartburn risk.
  3. Energy drinks can mask under-eating. The stimulant load can suppress appetite further on top of the GLP-1 effect, making it easier to drift into very low calorie intake. That is a real lean-mass-loss risk on a GLP-1 — see our protein calculator for daily protein targets to preserve lean mass.

For patients on a GLP-1, the conservative guidance is: skip the Celsius during the first 4 to 8 weeks after each dose escalation, and even after that, hold daily caffeine total to roughly 200 to 300 mg per day — not 600 to 800 mg. Water and protein, not stimulants, are the GLP-1 adherence currency.

How Celsius compares to the actual weight-loss interventions

Magnitude comparison

Total body-weight reduction at trial endpoint — Celsius energy drink (no weight-outcome RCT) compared with FDA-approved GLP-1 weight-loss medications. Sources: Roberts 2008, STEP-1, SURMOUNT-1.[2][6][7]

  • Celsius — 28-day RCT, no significant change0 % TBWL
    Roberts 2008 (n=60, 4 wk) — no body-composition difference vs placebo
  • Wegovy — semaglutide 2.4 mg (STEP-1, 68 wk)14.9 % TBWL
  • Zepbound — tirzepatide 15 mg (SURMOUNT-1, 72 wk)20.9 % TBWL
Total body-weight reduction at trial endpoint — Celsius energy drink (no weight-outcome RCT) compared with FDA-approved GLP-1 weight-loss medications. Sources: Roberts 2008, STEP-1, SURMOUNT-1.

The magnitude gap is not subtle. Celsius has one 28-day body-composition trial[2] with a null result. Semaglutide and tirzepatide have multi-thousand-patient 68 to 72-week trials with 14.9% and 20.9% body-weight reductions respectively[6][7]. They are not comparable interventions, and the marketing framing that positions a thermogenic drink as a weight-loss aid is doing most of the work the data does not.

What the evidence does and does not say

What the Celsius literature does say:

  • One small acute study (n=19) showed a 30 to 50 kcal thermogenic bump in the 3 hours after ingestion (Dalbo 2008[1]).
  • The effect is consistent with the well-established caffeine thermogenesis literature (Astrup 1990[3]).
  • A 28-day follow-up (n=60) showed no significant change in body weight, fat mass, or lean mass versus placebo (Roberts 2008[2]).

What the Celsius literature does NOT say:

  • There is no published RCT with body weight as the primary outcome, in a free-living population at matched calories, over 12+ weeks.
  • There is no evidence Celsius produces weight loss above what an isocaloric caffeine source (coffee, tea) would produce.
  • There is no evidence chromium picolinate, green tea blend, ginger, or guarana add meaningfully to body composition at the doses present in the can.
  • There is no head-to-head comparison versus FDA-approved obesity pharmacotherapy, because the interventions are not in the same magnitude class.

Bottom line

  • Celsius is an energy drink, not a weight-loss drug. The “burns calories” marketing is anchored to one small acute study in 19 young adults[1].
  • The net thermogenic effect is roughly 20 to 40 kcal per serving — trivial versus a meaningful calorie deficit.
  • The 28-day RCT in the same product showed no body composition change[2].
  • 200 mg of caffeine per can is real pharmacology. Two cans plus coffee can exceed 600 mg/day and meaningfully raise cardiovascular and anxiety risk in susceptible patients.
  • On a GLP-1, the conservative move is to cap total daily caffeine at roughly 200 to 300 mg and skip energy drinks during the first 4 to 8 weeks after each dose escalation.
  • If you want to lose weight, the intervention is the sustained calorie deficit and the protein-anchored eating pattern — not the can.

Related research and tools

Important disclaimer. This article is educational and does not constitute medical or nutrition advice. Patients with known cardiac arrhythmia, uncontrolled hypertension, pregnancy, anxiety disorders, or insomnia should discuss caffeine intake (including from energy drinks like Celsius) with their clinician. Energy drinks are not recommended for children or adolescents per American Academy of Pediatrics guidance. Patients on GLP-1 therapy who experience persistent nausea, reflux, or palpitations should not push through — contact the prescribing clinician. Brand-to-brand and SKU-to-SKU formulations of Celsius differ (Celsius Original vs Celsius Heat vs Celsius On-The-Go vs Celsius BCAA+Energy) — check the nutrition facts panel on the can you are drinking. PMIDs were independently verified against the PubMed E-utilities API on 2026-05-28.

Last verified: 2026-05-28. Next review: every 12 months, or sooner if new RCT evidence on Celsius or any thermogenic energy drink and weight outcomes is published.

References

  1. 1.Dalbo VJ, Roberts MD, Stout JR, Kerksick CM. Acute effects of ingesting a commercial thermogenic drink on changes in energy expenditure and markers of lipolysis. J Int Soc Sports Nutr. 2008. PMID: 18289388.
  2. 2.Roberts MD, Dalbo VJ, Hassell SE, Stout JR, Kerksick CM. Efficacy and safety of a popular thermogenic drink after 28 days of ingestion. J Int Soc Sports Nutr. 2008. PMID: 18950510.
  3. 3.Astrup A, Toubro S, Cannon S, Hein P, Breum L, Madsen J. Caffeine: a double-blind, placebo-controlled study of its thermogenic, metabolic, and cardiovascular effects in healthy volunteers. Am J Clin Nutr. 1990. PMID: 2333832.
  4. 4.Witkowski M, Nemet I, Alamri H, Wilcox J, Gupta N, et al. The artificial sweetener erythritol and cardiovascular event risk. Nat Med. 2023. PMID: 36849732.
  5. 5.Wharton S, Davies M, Dicker D, Lingvay I, Mosenzon O, Rubino DM, Pedersen SD. Managing the gastrointestinal side effects of GLP-1 receptor agonists in obesity: recommendations for clinical practice. Postgrad Med. 2022. PMID: 34775881.
  6. 6.Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, et al.; STEP 1 Study Group. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021. PMID: 33567185.
  7. 7.Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, et al.; SURMOUNT-1 Investigators. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022. PMID: 35658024.
  8. 8.Celsius Holdings, Inc. Celsius Original product label and nutrition facts panel — 200 mg caffeine, proprietary MetaPlus blend (green tea extract, guarana, ginger, chromium picolinate, B vitamins), zero sugar, sucralose plus erythritol sweetened. Manufacturer label. 2025. https://www.celsius.com/